Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
28431
CAS Number:
58994-96-0
Ranimustine
Synonym(s):
1-(2-chloroéthyl)-1-nitroso-3-[[(2 R ,3 S ,4 S ,5 R ,6 S -3,4,5-trihydroxy-6-méthoxy-oxan-2-yl]méthyl]urée
Documents
Available - Request Bulk Quote
Taille
Request Bulk Quote
Informations sur le produit

Ranimustine is a potent alkylating agent known for its application in oncology, particularly in the treatment of various types of cancers. This compound operates by disrupting the DNA structure of cancer cells, leading to cell death and inhibiting tumor growth. Its unique mechanism of action makes it a valuable option for researchers and healthcare professionals looking for effective chemotherapeutic agents. Ranimustine has shown promise in clinical settings, particularly in treating glioblastoma and other solid tumors, where traditional therapies may fall short.

In addition to its therapeutic uses, Ranimustine's chemical stability and solubility characteristics enhance its formulation potential, allowing for diverse delivery methods in pharmaceutical applications. Researchers appreciate its ability to cross the blood-brain barrier, which is critical for targeting central nervous system tumors. With ongoing studies exploring its efficacy and safety profiles, Ranimustine continues to hold significant potential in advancing cancer treatment protocols and improving patient outcomes.

Numéro CAS 
58994-96-0
Formule moléculaire
C10H18ClN3O7
Poids moléculaire 
327.72
Informations générales
Numéro CAS 
58994-96-0
Formule moléculaire
C10H18ClN3O7
Poids moléculaire 
327.72
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Ranimustine is widely utilized in research focused on:

  • Cancer Treatment: This compound is primarily used in oncology as a chemotherapeutic agent. It is effective against certain types of tumors, providing targeted therapy that can improve patient outcomes.
  • Combination Therapy: Ranimustine is often combined with other chemotherapeutic agents to enhance efficacy. This approach can help overcome drug resistance, making it a valuable option in complex treatment regimens.
  • Clinical Trials: Researchers are actively investigating its potential in clinical trials for various cancers, offering hope for new treatment protocols and improved survival rates.
  • Pharmaceutical Development: The compound serves as a model for developing new drugs with similar mechanisms of action, aiding in the advancement of cancer therapeutics.
  • Research on Mechanisms of Action: Scientists study Ranimustine to understand its biochemical interactions and effects on cancer cells, contributing to the broader knowledge of cancer biology and treatment strategies.

Citations